Biodegradable polymeric nanoparticles are widely recognized as efficacious drug delivery vehicles, yet the 24 rational engineering of nanoparticle surfaces in order to improve biodistribution, reduce clearance, and/or 25 improve targeting remains a significant challenge. We have previously demonstrated that an amphiphilic 26 conjugate of avidin and palmitic acid can be used to modify poly(lactic-co-glycolic acid) (PLGA) particle 27 surfaces to display functional avidin groups, allowing for the facile attachment of biotinylated ligands for 28 targeting or steric stabilization. Here, we hypothesized that the incorporation, density, and stability of surface-29 presented avidin could be modulated through varying the lipophilicity of its fatty acid conjugate partner. We 30 tested this hypothesis by generating a set of novel conjugates incorporating avidin and common fatty acids. 31 We found that conjugation to linoleic acid resulted in a~60% increase in the incorporation of avidin on the 32 nanoparticle surface compared to avidin-palmitic acid, which exhibited the highest avidin incorporation in 33 previous studies. Further, the linoleic acid-avidin conjugate yielded nanoparticles with enhanced ability to 34 bind biotinylated ligands compared to the previous method; nanoparticles modified with avidin-linoleic acid 35 bound~170% more biotin-HRP than those made with avidin-palmitic acid and~1300% more than particles 36 made without conjugated avidin. Most critically, increased ligand density on anti-CD4-targeted nanoparticles 37 formulated with the linoleic acid-avidin conjugate resulted in a 5% increase in binding of CD4 + T cells. Thus 38 we conclude that the novel avidin-linoleic acid conjugate facilitates enhanced ligand density on PLGA 39 nanoparticles, resulting in functional enhancement of cellular targeting. 40
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Characterization of avidin-lipid conjugates 169
Avidin-lipid conjugates were previously characterized by HPLC [17] .
170
We also examined the biotin-binding ability of conjugates using 4′-171 hydroxyazobenzene-2-carboxylic acid (HABA) (Sigma). HABA binds to 172 avidin to yield a yellow-orange complex that absorbs at 500 nm. (Fig. 3) . Addition of biotinylated PEG resulted in modest, statistically insignificant increase in apparent mean diameter with no effect on sample polydispersity (reported above columns). Each data point represents 10 measurements of the same sample before and after addition of biotin-PEG to the sample. Biotin-PEG alone did not alter background measurements. Fig. 3 . Lipid and polymer hydrophobicity influence avidin incorporation. Total protein content in NPs was measured using the colorimetric micro bicinchoninic assay (micro-BCA) kit. X-axis denotes lipid group conjugated to avidin, or non avidin-modified "blank" control, NPs. Nanoparticles were made with PLGA polymer containing 50:50 ratio of lactide:glycolide monomer (diagonal fill) or PLA polymer (100:0 ratio of lactide:glycolide monomer, solid fill). Conjugation to butanoic, palmitic, stearic, or linoleic acid resulted in a statistically significant increase in avidin incorporation in both PLGA and PLA NPs when compared to blank NPs and NPs made with unconjugated avidin (##, p b 0.05 by Student's t test). Linoleic acid was found to be a better conjugation partner than palmitic acid, resulting in a 100% increase in avidin incorporation in PLA NPs (***, p b 0.01 by Student's t test).
Increasing lipophilicity of the fatty acid-avidin conjugate (i. avidin/mg NP) compared to analogous PLGA nanoparticles (Fig. 3) .
329
Maximum avidin incorporation across all formulations was achieved by 330 the use of the avidin-linoleic acid or avidin-stearic acid conjugates; 331 compared to avidin-palmitic acid, utilization of linoleic acid as a 332 conjugate partner increased avidin incorporation in both PLGA and PLA
333
NPs by approximately 100% (Fig. 3) . This difference was highly 334 significant in the PLA NPs (***, p b 0.01 by Student's t test) (Fig. 3 ). doses of biotin-HRP (Fig. 5a ). NPs were subjected to three washes in PBS nanoparticle [35] . Enhanced ligand density may prove to be even 419 more potent in targeting applications that involve low target-receptor 420 avidity or low target antigen density [27] . 
433
The total amount and stability of avidin bound to the NP surface polymer resulted in a modest increase in avidin incorporation (Fig. 3) .
445
Conjugation to lipid increased the stability of avidin incorporation:
446 of the 7-10 μg of unconjugated avidin non-specifically incorporated in
447
NPs, more than 60% was released after one week of incubation in PBS
448
( Fig. 4a) . Conversely, conjugation to lipid reduced the loss to 14-34%
449
of total incorporated avidin conjugate (Fig. 4a) . Interestingly, while
450
we observed significant differences in the total amount of initially 451 incorporated avidin among lipid-modified groups, the comparative 452 differences between these groups in total amount of avidin lost over 453 one week were relatively small (Supplemental Fig. 2) . Moreover, the 
incorporated protein (Fig. 4b) 
